BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 32629115)

  • 1. A pharmacological perspective of chloroquine in SARS-CoV-2 infection: An old drug for the fight against a new coronavirus?
    Oscanoa TJ; Romero-Ortuno R; Carvajal A; Savarino A
    Int J Antimicrob Agents; 2020 Sep; 56(3):106078. PubMed ID: 32629115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in the use of chloroquine and hydroxychloroquine for the treatment of COVID-19.
    Sun J; Chen Y; Fan X; Wang X; Han Q; Liu Z
    Postgrad Med; 2020 Sep; 132(7):604-613. PubMed ID: 32496926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chloroquine and hydroxychloroquine in coronavirus disease 2019 (COVID-19). Facts, fiction and the hype: a critical appraisal.
    Khuroo MS
    Int J Antimicrob Agents; 2020 Sep; 56(3):106101. PubMed ID: 32687949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 Pandemic - A Narrative Review of the Potential Roles of Chloroquine and Hydroxychloroquine.
    de Barros CM; Almeida CAF; Pereira B; Costa KCM; Pinheiro FA; Maia LDB; Trindade CM; Garcia RCT; Torres LH; Diwan S; Boralli VB
    Pain Physician; 2020 Aug; 23(4S):S351-S366. PubMed ID: 32942793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review on possible modes of action of chloroquine/hydroxychloroquine: repurposing against SAR-CoV-2 (COVID-19) pandemic.
    Tripathy S; Dassarma B; Roy S; Chabalala H; Matsabisa MG
    Int J Antimicrob Agents; 2020 Aug; 56(2):106028. PubMed ID: 32450198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current pharmacological modalities for management of novel coronavirus disease 2019 (COVID-19) and the rationale for their utilization: A review.
    Giovane RA; Rezai S; Cleland E; Henderson CE
    Rev Med Virol; 2020 Sep; 30(5):e2136. PubMed ID: 32644275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection.
    Braz HLB; Silveira JAM; Marinho AD; de Moraes MEA; Moraes Filho MO; Monteiro HSA; Jorge RJB
    Int J Antimicrob Agents; 2020 Sep; 56(3):106119. PubMed ID: 32738306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis?
    Quiros Roldan E; Biasiotto G; Magro P; Zanella I
    Pharmacol Res; 2020 Aug; 158():104904. PubMed ID: 32430286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review.
    Hashem AM; Alghamdi BS; Algaissi AA; Alshehri FS; Bukhari A; Alfaleh MA; Memish ZA
    Travel Med Infect Dis; 2020; 35():101735. PubMed ID: 32387694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal.
    Fantini J; Chahinian H; Yahi N
    Int J Antimicrob Agents; 2020 Aug; 56(2):106020. PubMed ID: 32405156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease-19 (COVID-19).
    Shah S; Das S; Jain A; Misra DP; Negi VS
    Int J Rheum Dis; 2020 May; 23(5):613-619. PubMed ID: 32281213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evidence for repurposing chloroquine and hydroxychloroquine as antiviral agents: a systematic review.
    Rodrigo C; Fernando SD; Rajapakse S
    Clin Microbiol Infect; 2020 Aug; 26(8):979-987. PubMed ID: 32470568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond Anti-viral Effects of Chloroquine/Hydroxychloroquine.
    Gies V; Bekaddour N; Dieudonné Y; Guffroy A; Frenger Q; Gros F; Rodero MP; Herbeuval JP; Korganow AS
    Front Immunol; 2020; 11():1409. PubMed ID: 32714335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Hydroxychloroquine/Chloroquine in COVID-19 Therapy: Two Sides of the Coin.
    Fatima U; Rizvi SSA; Fatima S; Hassan MI
    J Interferon Cytokine Res; 2020 Oct; 40(10):469-471. PubMed ID: 32881593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of lethal human coronaviruses.
    Chen B; Tian EK; He B; Tian L; Han R; Wang S; Xiang Q; Zhang S; El Arnaout T; Cheng W
    Signal Transduct Target Ther; 2020 Jun; 5(1):89. PubMed ID: 32533062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chloroquine and Hydroxychloroquine in COVID-19: Practice Implications for Healthcare Professionals.
    Mallhi TH; Ahmad A; Butt MH; Misbah S; Khan YH; Alotaibi NH
    J Coll Physicians Surg Pak; 2020 Oct; 30(10):124-128. PubMed ID: 33115586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elucidating the Pivotal Immunomodulatory and Anti-Inflammatory Potentials of Chloroquine and Hydroxychloroquine.
    Richard SA; Kampo S; Hechavarria ME; Sackey M; Buunaaim ADB; Kuugbee ED; Anabah TW
    J Immunol Res; 2020; 2020():4582612. PubMed ID: 33062720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2.
    Catanzaro M; Fagiani F; Racchi M; Corsini E; Govoni S; Lanni C
    Signal Transduct Target Ther; 2020 May; 5(1):84. PubMed ID: 32467561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Janus sword actions of chloroquine and hydroxychloroquine against COVID-19.
    Chen X; Geiger JD
    Cell Signal; 2020 Sep; 73():109706. PubMed ID: 32629149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of chloroquine and hydroxychloroquine on COVID-19 virological outcomes: An updated meta-analysis.
    Das RR; Behera B; Mishra B; Naik SS
    Indian J Med Microbiol; 2020; 38(3 & 4):265-272. PubMed ID: 33154234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.